ConductScience.org, home

Paper61820

Pluripotent teratocarcinoma-thymus somatic cell hybrids.

Miller RA and 1 other. Cell, 1976. Cited by 157 papers, by iCite.

Cite this record

ConductScience Library. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Papers, record 61820. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/61820

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pluripotent teratocarcinoma-thymus somatic cell hybrids.
PubMed
Journal
Cell
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
157
iCite
Relative citation ratio, by iCite
2.3
iCite
Revised in PubMed
2019-07-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miller RAR A
2Ruddle FHF H

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hybrid CellsMajor topic
T-LymphocytesMajor topic
TeratomaMajor topic
Animals
Cell Fusion
Cell Line
Glucose-6-Phosphate Isomerase
Karyotyping
Mice
Mice, Nude
Neoplasm Transplantation
Neoplasms, Experimental
alpha-Fetoproteins

Source PubMed

Download CSV of topics

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.

PMIDTitleJournalYearIn PapersSource
42168743Cell Fusion in Reprogramming and Regeneration.Adv Exp Med Biol2026https://conductscience.org/library/papers/42168743PubMed
36964256Human iPS Cells for Clinical Applications and Cellular Products.Handb Exp Pharmacol2023https://conductscience.org/library/papers/36964256PubMed
36389274Cell pairing for biological analysis in microfluidic devices.Biomicrofluidics2022https://conductscience.org/library/papers/36389274PubMed
33668852Embryonic Environmental Niche Reprograms Somatic Cells to Express Pluripotency Markers and Participate in Adult Chimaeras.Cells2021https://conductscience.org/library/papers/33668852PubMed
32198717All roads lead to Rome: the many ways to pluripotency.J Assist Reprod Genet2020https://conductscience.org/library/papers/32198717PubMed
30053890The march of pluripotent stem cells in cardiovascular regenerative medicine.Stem Cell Res Ther2018https://conductscience.org/library/papers/30053890PubMed
29786549Pluripotent stem cells: induction and self-renewal.Philos Trans R Soc Lond B Biol Sci2018https://conductscience.org/library/papers/29786549PubMed
28596585Tetraploid embryonic stem cells can contribute to the development of chimeric fetuses and chimeric extraembryonic tissues.Sci Rep2017https://conductscience.org/library/papers/28596585PubMed
26997336Single-cell RNA-seq reveals activation of unique gene groups as a consequence of stem cell-parenchymal cell fusion.Sci Rep2016https://conductscience.org/library/papers/26997336PubMed
26844759The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.Prog Neurobiol2017https://conductscience.org/library/papers/26844759PubMed
26626939Induced Pluripotency and Epigenetic Reprogramming.Cold Spring Harb Perspect Biol2015https://conductscience.org/library/papers/26626939PubMed
26589198Erase and Rewind: Epigenetic Conversion of Cell Fate.Stem Cell Rev Rep2016https://conductscience.org/library/papers/26589198PubMed
25820261Reprogramming of cell fate: epigenetic memory and the erasure of memories past.EMBO J2015https://conductscience.org/library/papers/25820261PubMed
25408868Progress and bottleneck in induced pluripotency.Cell Regen2012https://conductscience.org/library/papers/25408868PubMed
24855516Somatic cell dedifferentiation/reprogramming for regenerative medicine.Int J Stem Cells2009https://conductscience.org/library/papers/24855516PubMed
24832604Understanding the roadmaps to induced pluripotency.Cell Death Dis2014https://conductscience.org/library/papers/24832604PubMed
24764131Somatic Cell Reprogramming into Cardiovascular Lineages.J Cardiovasc Pharmacol Ther2014https://conductscience.org/library/papers/24764131PubMed
24638034Generation of neural progenitor cells by chemical cocktails and hypoxia.Cell Res2014https://conductscience.org/library/papers/24638034PubMed
24621955Induction of pluripotency by defined factors.Proc Jpn Acad Ser B Phys Biol Sci2014https://conductscience.org/library/papers/24621955PubMed
24052937From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize.Stem Cell Reports2013https://conductscience.org/library/papers/24052937PubMed

See all 60 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GPI2821PubTator's text mininghttps://conductscience.org/library/genes/2821

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/61820

GET https://conductscience.org/api/papers/v1/61820/cited_by?page=2